V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210033350 | 210033514 | 1.63 | 62.25 | Disease modification (D) | null | 2017-07-23 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210033030 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033351 | 210012103 | 1.75 | 84.8 | Curative (C) | 2013-10-16 | 2013-11-13 | Imatinib 400mg | N | null | 210033089 | IMATINIB |
| 210033352 | 210021697 | 1.52 | 47.8 | Disease modification (D) | 2014-10-20 | 2014-10-22 | Imatinib 400mg | N | N | 210033139 | IMATINIB |
| 210033353 | 210027626 | 1.64 | 89.8 | Curative (C) | 2018-02-19 | 2018-03-31 | ALL UKALL2003 TRIAL | N | N | 210033143 | UKALL 2003 |
| 210033354 | 210027627 | null | null | Disease modification (D) | 2016-01-05 | 2016-01-11 | CHLORAMBUCIL + OBINUTUZUMAB | 1 | N | 210033187 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033355 | 210012125 | 1.8 | 84 | Curative (C) | 2016-10-27 | 2016-12-14 | IDELALISIB + RITUXIMAB | 2 | N | 210033206 | IDELALISIB + RITUXIMAB |
| 210033356 | 210021703 | 1.65 | 84 | Curative (C) | 2017-03-22 | 2017-03-22 | ALL UKALL60+ TRIAL | 2 | N | 210033216 | UKALL60+ |
| 210033357 | 210012131 | 1.77 | 99 | Curative (C) | 2016-07-26 | 2016-11-21 | R Chlorambucil | N | N | 210033250 | CHLORAMBUCIL + RITUXIMAB |
| 210033358 | 210021708 | 0 | 53.7 | Curative (C) | 2013-10-27 | 2014-06-14 | ALL UKALL2003 TRIAL | 02 | N | 210033272 | UKALL 2003 |
| 210033359 | 210012140 | null | null | Disease modification (D) | 2013-04-22 | 2013-12-15 | CHLORAMBUCIL + OBINUTUZUMAB | 99 | null | 210033299 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033360 | 210012147 | 1.82 | 88 | Curative (C) | null | 2015-03-08 | CHLORAMBUCIL + RITUXIMAB | null | null | 210033319 | CHLORAMBUCIL + RITUXIMAB |
| 210033361 | 210012149 | 1.67 | 47 | Disease modification (D) | 2014-02-28 | 2014-05-31 | IDELALISIB + RITUXIMAB | Y | N | 210033321 | IDELALISIB + RITUXIMAB |
| 210033362 | 210012156 | 1.82 | 54 | Adjuvant (A) | 2016-04-26 | 2016-05-03 | ALL UKALL2003 TRIAL | N | N | 210033375 | UKALL 2003 |
| 210033363 | 210021730 | null | 93.25 | Curative (C) | null | 2015-03-27 | Imatinib 200mg | null | null | 210033416 | IMATINIB |
| 210033364 | 210012174 | 1.57 | 60.7 | Curative (C) | 2018-09-23 | 2018-09-30 | CHLORAMBUCIL + RITUXIMAB | N | N | 210033439 | CHLORAMBUCIL + RITUXIMAB |
| 210033365 | 210012180 | 1.78 | null | Palliative (P) | 2016-12-17 | 2017-02-18 | ALL UKALL60+ TRIAL | N | null | 210033462 | UKALL60+ |
| 210033366 | 210027655 | 0 | 76.5 | Curative (C) | 2015-05-23 | 2015-05-31 | Triple / Double Intrathecal Therapy | 02 | N | 210033486 | TRIPLE INTRATHECAL |
| 210033367 | 210012191 | 1.6 | null | Palliative (P) | 2018-06-25 | 2018-06-25 | METHOTREXATE | N | null | 210033503 | METHOTREXATE |
| 210033368 | 210027656 | 1.7 | 77 | Curative (C) | 2016-07-30 | 2016-07-30 | IMATINIB | 02 | N | 210033509 | IMATINIB |
| 210033369 | 210012197 | null | null | Palliative (P) | 2017-10-02 | 2018-01-01 | CHLORAMBUCIL + OBINUTUZUMAB | Y | N | 210033512 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033370 | 210012200 | 1.76 | 91.2 | null | 2013-02-16 | 2013-05-10 | ALL UKALL60+ TRIAL | null | null | 210033533 | UKALL60+ |
| 210033371 | 210021753 | 1.72 | 74.4 | Palliative (P) | 2016-09-27 | 2016-12-25 | IMATINIB | N | N | 210033611 | IMATINIB |
| 210033372 | 210012218 | null | null | Disease modification (D) | 2016-03-13 | 2016-06-12 | IMATINIB | N | null | 210033621 | IMATINIB |
| 210033374 | 210012221 | 1.52 | 64.3 | Curative (C) | 2017-09-22 | 2017-09-22 | IMATINIB | N | N | 210033652 | IMATINIB |
| 210033375 | 210012225 | 1.63 | 82.7 | Curative (C) | 2017-08-03 | 2017-11-06 | IDELALISIB + RITUXIMAB | null | N | 210033656 | IDELALISIB + RITUXIMAB |
| 210033376 | 210012228 | 1.59 | 64.8 | Curative (C) | 2015-09-30 | 2015-12-16 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210033690 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033377 | 210012231 | 1.68 | 0 | Palliative (P) | 2016-01-02 | 2016-07-09 | CHLORAMBUCIL + OBINUTUZUMAB | 2 | N | 210033709 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033378 | 210021765 | 1.56 | 55.9 | Curative (C) | 2012-02-26 | 2013-05-28 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210033710 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033379 | 210012233 | 1.77 | 30.6 | Palliative (P) | 2015-02-28 | 2015-07-13 | METHOTREXATE | N | N | 210033717 | METHOTREXATE |
| 210033380 | 210012236 | null | 29.3 | Disease modification (D) | 2017-09-16 | 2017-09-16 | METHOTREXATE | 02 | null | 210033742 | METHOTREXATE |
| 210033381 | 210021772 | null | 77.2 | Disease modification (D) | null | 2015-10-15 | ALL UKALL60+ TRIAL | N | N | 210033764 | UKALL60+ |
| 210033382 | 210012253 | 1.89 | 57 | Adjuvant (A) | 2015-11-09 | 2015-11-14 | CHLORAMBUCIL + OBINUTUZUMAB | null | null | 210033792 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033383 | 210012266 | -1 | 85.899 | Curative (C) | null | 2016-07-23 | ALL UKALL2003 TRIAL | N | N | 210033831 | UKALL 2003 |
| 210033384 | 210021786 | 1.73 | 76 | Curative (C) | 2015-07-08 | 2015-09-15 | ALL UKALL60+ TRIAL | N | N | 210033839 | UKALL60+ |
| 210033385 | 210012269 | null | 54 | Adjuvant (A) | 2018-04-27 | 2018-05-11 | IDELALISIB + RITUXIMAB | 2 | N | 210033851 | IDELALISIB + RITUXIMAB |
| 210033386 | 210012272 | 1.54 | 71.3 | Curative (C) | 2017-03-28 | 2017-03-29 | IDELALISIB + RITUXIMAB | Y | N | 210033859 | IDELALISIB + RITUXIMAB |
| 210033387 | 210012276 | 0 | 67 | Curative (C) | 2016-01-18 | 2016-01-18 | CHLORAMBUCIL + OBINUTUZUMAB | Y | N | 210033868 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033388 | 210021793 | 1.79 | null | Curative (C) | 2013-07-21 | 2013-08-28 | ALL UKALL2003 TRIAL | N | null | 210033900 | UKALL 2003 |
| 210033389 | 210012292 | null | 127 | Curative (C) | 2018-07-05 | 2019-03-23 | ALL UKALL2003 TRIAL | N | null | 210033985 | UKALL 2003 |
| 210033390 | 210012296 | 1.57 | 17.3 | Disease modification (D) | 2018-11-18 | 2018-11-18 | ALL UKALL60+ TRIAL | N | null | 210034017 | UKALL60+ |
| 210033391 | 210012301 | null | 60.4 | Adjuvant (A) | 2016-03-11 | 2017-06-11 | IMATINIB | 02 | null | 210034037 | IMATINIB |
| 210033392 | 210021815 | 1.79 | 70.6 | Adjuvant (A) | 2017-08-27 | 2017-09-03 | CHOP R - 21 days | N | N | 210034070 | CHOP R |
| 210033393 | 210012313 | 1.7 | 102 | Curative (C) | 2015-07-01 | 2015-07-16 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 210034090 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210033394 | 210012315 | null | 87 | Curative (C) | null | 2018-03-11 | MERCAPTOPURINE + METHOTREXATE | N | N | 210034098 | MERCAPTOPURINE + METHOTREXATE |
| 210033395 | 210036148 | null | 70.8 | Curative (C) | 2017-02-13 | 2017-06-12 | Alemtuzumab | N | N | 210034115 | ALEMTUZUMAB |
| 210033396 | 210012324 | 1.9 | 77.75 | Curative (C) | 2018-07-01 | 2019-02-27 | Etoposide IV | Y | N | 210034118 | ETOPOSIDE |
| 210033397 | 210027702 | 1.6 | 63 | null | 2018-04-16 | 2018-04-21 | CHOP R - 21 days | N | null | 210034139 | CHOP R |
| 210033398 | 210012330 | 1.79 | null | Curative (C) | 2016-09-14 | 2016-09-14 | FLAG + Idarubicin | 02 | null | 210034157 | FLAG + IDARUBICIN |
| 210033399 | 210027704 | 0 | 60.4 | Curative (C) | 2019-11-01 | 2019-11-02 | Etoposide Conditioning | N | N | 210034173 | ETOPOSIDE |
| 210033400 | 210021831 | null | 82.5 | null | 2017-12-28 | 2018-04-20 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | 02 | N | 210034178 | UKALLR3 |